Effect of Longitudinal Sleep Monitoring on Diagnosis and Treatment Decision in Patients with Suspected Obstructive Sleep Apnea
ELSA
1 other identifier
observational
130
1 country
1
Brief Summary
Obstructive sleep apnea (OSA) is a highly prevalent sleep-disordered breathing disease, caused by recurrent episodes of partial or complete collapse of the upper airway during sleep, resulting in intermittent hypoxia, fragmented sleep, fluctuations in blood pressure, and increased sympathetic nervous system activity. A single-night sleep study (i.e. respiratory polygraphy or polysomnography) is currently considered to be the gold standard for diagnosing OSA. However, recent studies suggest a significant intra-individual night-to-night variability of respiratory events, leading to the hypothesis that one single-night study might not reflect an accurate picture of the disease. Part A: Patients with suspected obstructive sleep apnea, referred to our clinic, undergo the regular diagnostic procedure recommended by the current guidelines. In addition to the in-hospital single-night sleep study, these patients will perform 14 nights of pulse-oximetry at home. By computing and analysing sensitivity and specificity of every additional night, the investigator will answer the questions how many nights of sleep monitoring by home oximetry are necessary to diagnose OSA reliably, and how longitudinal sleep monitoring could reduce the number of false-negative and false- positive results compared to the in-hospital single-night study. Part B: Based on the patients' data of part A, the investigator will develop a questionnaire and present anonymized cases to experts in the field of sleep medicine. Thereby, the investigator will evaluate if the additional information of repeated nocturnal pulse-oximetries changes the experts' decision making regarding diagnosis and treatment of OSA. In a second step, the investigator will perform a classical Delphi study with a panel of experts in sleep medicine to establish consensus on repeated sleep studies and how they should be used for diagnosis and treatment in patients with suspected OSA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2019
CompletedFirst Posted
Study publicly available on registry
January 28, 2019
CompletedStudy Start
First participant enrolled
February 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2025
CompletedDecember 10, 2024
December 1, 2024
5.2 years
January 22, 2019
December 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The accuracy of 1-13 nights of pulse-oximetry compared to the mean ODI of 14 consecutive nights
"Sensitivity" and "specificity" for every additional night will be assessed
14 nights of pulse-oximetry
Decision making of a panel of experts in the field of sleep medicine regarding diagnosis and severity of OSA (no OSA, mild, moderate, severe) with/without the additional information of longitudinal sleep monitoring
14 nights of pulse-oximetry
Secondary Outcomes (5)
ODI variability measured in 14 consecutive nights of pulse-oximetry
14 nights of pulse-oximetry
Change of OSA severity class (no OSA, mild, moderate, severe OSA) during 14 nights of pulse-oximetry due to ODI variability
14 nights of pulse-oximetry
Change of OSA severity class (no OSA, mild, moderate, severe OSA) diagnosed by in-hospital single-night sleep study vs repeated measurements by pulse-oximetry
14 nights of pulse-oximetry
Decision making of a panel of experts in field of sleep medicine regarding treatment decisions (CPAP yes/no) with/without the additional information of longitudinal sleep monitoring
14 nights of pulse-oximetry
Establish consensus on repeated sleep studies and their use in diagnosis and treatment in patients with suspected OSA
14 nights of pulse-oximetry
Study Arms (1)
Suspected OSA
Interventions
Patients with suspected OSA will be monitored with 14 nights of pulse-oximetry prior to the already planned in-hospital single-night sleep study at the University Hospital Zurich
Eligibility Criteria
Patients with suspected obstructive sleep apnea
You may qualify if:
- Informed consent
- Suspected obstructive sleep apnea
- ≥18 years old
You may not qualify if:
- Suspected or diagnosed sleeping-disordered breathing other than OSA
- Moribund or severe disease prohibiting protocol adherence especially COPD GOLD III-IV and heart failure NYHA III-IV
- Patients receiving oxygen therapy or home ventilation
- Continuous positive airway pressure treatment for OSA at baseline
- Physical or intellectual impairment precluding informed consent or protocol adherence
- Pregnant patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Malcolm Kohlerlead
Study Sites (1)
University Hospital Zurich
Zurich, Canton of Zurich, 8091, Switzerland
Related Publications (1)
Roeder M, Sievi NA, Bradicich M, Grewe FA, Siegfried S, Gaisl T, Kohler M. The Accuracy of Repeated Sleep Studies in OSA: A Longitudinal Observational Study With 14 Nights of Oxygen Saturation Monitoring. Chest. 2021 Mar;159(3):1222-1231. doi: 10.1016/j.chest.2020.09.098. Epub 2020 Sep 25.
PMID: 32980370DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Malcolm Kohler, Prof. Dr. med.
University of Zurich
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Head of the department of pulmonology
Study Record Dates
First Submitted
January 22, 2019
First Posted
January 28, 2019
Study Start
February 1, 2019
Primary Completion
April 30, 2024
Study Completion
April 30, 2025
Last Updated
December 10, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share